The decreased EPHB3 expression was correlated with the reduced survival rate of GBM patients, and blocking the PI3K/Akt/mTOR pathway sensitised GBM cells to apoptosis upon TMZ treatment.29 Here, EPHB3 is linked to glioblastoma.